Dr. Mohammed M. Jamjoom, a distinguished contributor in the pharmaceutical sector, holds a PhD in Pharmaceutical Economics and currently spearheads operations at Jamjoom Pharma, a leading pharmaceutical company in Saudi Arabia. He is also a co-founder of Juleb, showcasing his entrepreneurial acumen and commitment to innovation in healthcare. Dr. Jamjoom's extensive research delves into critical areas of pricing, regulations, and consumer behavior, contributing valuable insights to the pharmaceutical industry. His expertise in these domains is not only academic but also practical, influencing policies and practices within his professional endeavors. In his role with Juleb, Dr. Jamjoom further emphasizes his ability to navigate and innovate within the complex pharmaceutical landscape. His foresight in recognizing and addressing emerging trends in the industry underscores his dedication to advancing pharmaceutical care. As one of the youngest experts in his field in Saudi Arabia, Dr. Jamjoom is renowned for challenging the status quo and driving excellence. His contributions extend beyond corporate achievements, significantly impacting the broader pharmaceutical sector in alignment with Saudi Arabia's Vision 2030.
General Inquiries
Forbes Middle East is a licensee of Forbes Media and extends the Forbes brand of journalism across the Arab world. Forbes Middle East’s distinctive editorial style attracts a readership of Arab leaders, entrepreneurs, C-level executives, government officials and investors united by a belief in the spirit of free enterprise and entrepreneurial values.Across the region, Forbes Middle East sets the pace for preemptive business journalism. By uncovering trends and anticipating opportunities in the regional marketplace, each monthly issue brings top executives the information critical to their success – in both Arabic and English language editions. The magazine researches and publishes original rankings, based on methodologies set by Forbes Media.